Non-contrast Abbreviated MRI for Secondary Surveillance of HCC

The Role of Non-contrast Abbreviated MRI for Secondary Surveillance of Hepatocellular Carcinoma After Curative Treatment: a Prospective Multicenter Study

This prospective multicenter study aimed to compare the diagnostic performance of non-contrast abbreviated MRI in detecting recurrent HCC after curative treatment to that of contrast-enhanced liver CT.

This study was designed as a prospective single-arm intra-individual comparison multicenter study

Inclusion Criteria:

• Age between 20-year old and 85-year old
• Patients with a history of curative treatment for HCC including surgical resection or local ablation
• No recurrence after curative treatment of HCC for more than two years
• Patient who has the plan to perform contrast-enhanced liver CT for secondary surveillance for HCC (i.e., to detect de novo or recurrent HCC)

Exclusion Criteria:

• Estimated GFR less than 60
• Previous history of severe allergic reaction to the iodinated contrast agent
• Patients with claustrophobia who can't undergo MR examination
• Patients having cochlear implants or cardiac pacemaker